SENSEX NIFTY

Fda

Apr 30, 2016 at 12:02 | Source: CNBC-TV18
The past few years have been rough of Indian pharma companies, what with the US FDA raking them over the coals over alleged manufacturing lapses and discrepancies.
Apr 29, 2016 at 09:29 | Source: CNBC-TV18
Company will continue with tie-ups for biosimilar products. These will first be launched in India and then in other markets, says Satish Reddy, Chairman of Dr Reddys Lab.
Apr 26, 2016 at 16:49 | Source: Moneycontrol.com
Brokerage house CLSA says the Indian generics industry is unlikely to be impacted in the medium-term. This is because the Democrats, who are looking to negotiate drug prices, need a majority in both the houses to bring in any change, which doesnt seem possible soon.
Apr 26, 2016 at 11:16 | Source: CNBC-TV18
The cigarette companies have not yet given undertaking claiming return of seized cigarettes worth Rs 300 crore from Maharashtra, reports Priya Sheth of CNBC-TV18, quoting sources.
Apr 26, 2016 at 09:02 | Source: CNBC-TV18
The US dollar weakened against major currencies on expectations of a dovish US Fed. The US FDA rate hikes, if they do happen, could strengthen the currency, says Sameer Goel of Deutsche Bank.
Apr 25, 2016 at 17:40 | Source: PTI
The experts are prompting regulators at the US Food and Drug Administration (FDA) to have a broad "open-minded" perspective when it comes to regulating e-cigarettes.
Apr 25, 2016 at 13:00 | Source: CNBC-TV18
Pharma stocks, which are reeling under US FDA actions, are value-emerging names, says Mahantesh Sabarad, Deputy-VP of SBICAP.
Apr 20, 2016 at 13:33 | Source: CNBC-TV18
Inspections carried out by the US FDA on drug companies in India have risen over 200 percent from FY07 till FY15. The figure pales in comparison to the rise seen in China of about 500 percent.
Apr 20, 2016 at 11:45 | Source: Reuters
The drugmaker, based in the southern Indian city of Hyderabad, is the latest drugmaker in the country to get such a warning. Similar data-integrity issues found by the FDA at other Indian drug firms have led to dozens of manufacturing plants being banned in recent years.
Messages on Fda »

Multiplier@
999

New Member

205 Followers

Divis Labs  

best time to grab ..don`t get panic for short term fda news ..every dip is a excellent buying opportunity ..added some more today..best regards

about 2 hrs 9 min 16 sec ago

Divis Labs  

getting FDA clearance(once its complicated ). is bit tough , they pointed out lapses in quality and some irregularities in records , we must see how long it takes Meanwhile better to be distant to this stock.Even the process itself is time consuming..

about 2 hrs 15 min 27 sec ago

AV11

New Member

1 Followers

Marksans Pharma  

mp is well placed for a better beneficiary of policy changes...more so with a localised manufacturing in us and already 2 fda approvals in last 2 months..

about 2 hrs 18 min 37 sec ago

marksman007

New Member

0 Follower

Omkar Special  

Zeroing in on Target / Target Zero FDA inspecting pharma cos, share price diving, If it starts inspecting intermidiaries manufacturers ...

about 3 hrs 58 min 25 sec ago

cpmc

Silver Member

35 Followers

Natco Pharma  

of the demonetisation and currency shortfall affecting retail trade off takes. My guess overall - Q3 shud be similar to Q2 or slightly better in overall earnings. Q4 shud be a blockbuster. Let`s see how it unfolds For the upcoming week - all eyes and ears will be on the Kothur FDA outcome and TAD update on Mylan`s g

12.13 PM Jan 21st

mayankiocl1
0

New Member

2 Followers

Coral Labs  

by the demonetisation and the recent fall in rupee against the dollar could very well provide a positive impact on their cash flow and q3 results. coral labs is exporting their procuts in the developing and under developed countries where the fda issue is not bitng the pharma company.

12.38 PM Jan 20th

StockTips

Platinum Member

3611 Followers

Panacea Biotec  

More FDA approvals

11.41 AM Jan 20th

kalpataru70

Platinum Member

497 Followers

Aurobindo Pharm  

Aurobindo Pharma has opened in the green on the bourses as it gets US FDA`s nod for Ritonavir tablets. This medicine is used to treat HIV/AIDS.

2.20 PM Jan 19th

cpmc

Silver Member

35 Followers

Natco Pharma  

and what will be an important milestone to achieve. My guess is that (on approval) Mylan/Natco will launch the 20 mg but will be cautious before deciding in launching the 40 mg. All said, the approvals need to come from the FDA which will provide a good indication for the next things that can follow

12.45 PM Jan 19th

BlueOcean75

New Member

2 Followers

Natco Pharma  

I think this is related to Copaxone 40mg... 20 mg is awaited for FDA approval which is expected soon. Please correct me if I`m wrong

11.28 AM Jan 19th

News across the web »
Jan 11, 2017 at 22:30 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.